Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the ... (11.1% 8.3% 11.6% Capi...)

HOME >> BIOLOGY >> TECHNOLOGY

Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year

Date:11/10/2008

11.1% 8.3% 11.6%

Capital sales gross margin % 40.7% 42.1% 43.5%

Rental revenues gross margin % 52.6% 51.9% 53.0%

Total gross margin % 44.4% 45.0% 46.3%

Operating Expenses (1) 537 591 610

Operating Income (1) 133 143 169

Tax Rate (2) 27.3% 34.0% 34.0%

Income from Continuing Operations (1) $88 $88 $104

Earnings per share $1.07 $1.40 $1.64

Earnings per share -

Adjusted (1)(2)(3) $1.40 $1.40 $1.64

(1) 2008 adjusted results exclude from the applicable line items

special charges recognized in Q1 and Q4 2008, as well as one time

charges incurred in Q2 2008 for an equity award modification, debt

extinguishment, and other costs related to the spin-off of the funeral

services business. See Non-GAAP Financial Disclosures and

Reconciliations presented earlier.

(2) Tax rate includes all discrete period tax benefits recognized for

fiscal year 2008. 2009 tax rate does not reflect any future discrete

period tax items which may be recognized.

(3) Earnings per share - Adjusted in the above presentation for

fiscal 2008 have not been adjusted to remove the effects of discrete

period tax adjustments recognized in any of the periods presented.

Discrete period tax adjustments are routinely recognized throughout

any given year under a variety of circumstances and are highly

subjective in nature. For fiscal year 2008, discrete tax benefits

totaled $8.3 million ($0.13 per share), $7.8 million ($0.12 per share)

of which was recognized in the third fiscal quar
'/>"/>

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Related biology technology :

1. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
2. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
3. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
4. BMP Sunstone Reports Third Quarter 2008 Financial Results
5. Endocare Reports Financial Results for Third Quarter 2008
6. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
7. Isis Reports Financial Results and Highlights for Third Quarter of 2008
8. OncoGenex Reports Third Quarter Financial Results
9. American Oriental Bioengineering Reports Third Quarter 2008 Financial Results
10. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
11. Dendreon Reports Third Quarter 2008 Financial Results

Post Your Comments:

Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the ...(11.1% 8.3% 11.6% Capi...)